AbbVie: Democratizing Data and Removing Silos with a Data Catalog
This is a promotional page for an on-demand Alation webinar rather than a written case study. It states AbbVie faces challenges democratizing data given 'a broad mix of internal and external data and multiple user personas, each with multiple use cases,' and that AbbVie implemented the Alation Data Catalog aiming to 'break down silos, increase discoverability, and foster collaboration.' The page features speakers Karthik Kandamuri (AbbVie, analytics innovation) and Mitesh Shah (Alation VP of product marketing), covering webinar topics like data-democratization roles and removing AI/analytics barriers. No specific quantitative outcomes, results, or direct quotes about achieved results are included on the page.
Alation is a data-catalog and data-intelligence platform that tells a pharma team what data actually exists, who owns it, and whether it is trustworthy enough to support an AI use case.
This sits in the Design & Stress-Test stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to scope, prototype and benchmark an AI use case before committing to build it — data-catalog, sandbox and evaluation platforms.
Published by Alation on its own site — read the original case study on alation.com ↗
Related use cases
- 01used Alation's data-catalog/AI-analytics platform to break down cross-divisional data silos and help identify/treat rare diseases (cited example: identifying patients with transthyretin cardiomyopathy, often misdiagnosed
- 02How CHOP Is Building an AI-Ready Healthcare Organization with Data Intelligence and Trust
- 03Customer Case Study: HBF Health Ltd.
- 04Alation: The Front Door to Data Intelligence at Sallie Mae
- 052,500+ users use Alation to find data (non-health
- 06The $25 Million Reason Georgia-Pacific Rebuilt Its Data Foundation